Evidence map›Paper›PMID 37211093›Full record

ArticleThe Journal of biological chemistry2023

Control of atypical PKCι membrane dissociation by tyrosine phosphorylation within a PB1-C1 interdomain interface.

Mathias Cobbaut, Neil Q McDonald, Peter J Parker

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mathias CobbautSignalling and Structural Biology Laboratory, The Francis Crick Institute, London, UK; Protein Phosphorylation Laboratory, The Francis Crick Institute, London, UK. Electronic address: mathias.cobbaut@crick.ac.uk.
Neil Q McDonaldSignalling and Structural Biology Laboratory, The Francis Crick Institute, London, UK; Department of Biological Sciences, Institute of Structural and Molecular Biology, Birkbeck College, London, UK. Electronic address: neil.mcdonald@crick.ac.uk.
Peter J ParkerProtein Phosphorylation Laboratory, The Francis Crick Institute, London, UK; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK. Electronic address: peter.parker@crick.ac.uk.

Funding

Cancer Research UKMedical Research CouncilWellcome Trust CC2068Wellcome Trust CC2140
6 · The paper itself

Abstract

Atypical PKCs are cell polarity kinases that operate at the plasma membrane where they function within multiple molecular complexes to contribute to the establishment and maintenance of polarity. In contrast to the classical and novel PKCs, atypical PKCs do not respond to diacylglycerol cues to bind the membrane compartment. Until recently, it was not clear how aPKCs are recruited; whether aPKCs can directly interact with membranes or whether they are dependent on other protein interactors to do so. Two recent studies identified the pseudosubstrate region and the C1 domain as direct membrane interaction modules; however, their relative importance and coupling are unknown. We combined molecular modeling and functional assays to show that the regulatory module of aPKCι, comprising the PB1 pseudosubstrate and C1 domains, forms a cooperative and spatially continuous invariant membrane interaction platform. Furthermore, we show the coordinated orientation of membrane-binding elements within the regulatory module requires a key PB1-C1 interfacial β-strand (beta-strand linker). We show this element contains a highly conserved Tyr residue that can be phosphorylated and that negatively regulates the integrity of the regulatory module, leading to membrane release. We thus expose a hitherto unknown regulatory mechanism of aPKCι membrane binding and release during cell polarization.

Indexed as

Cell MembraneProtein Kinase CProtein Processing, Post-TranslationalCell PolarityHEK293 CellsHumansMutationPhosphorylationProtein BindingTyrosinePKC-3 proteinProtein Kinase CTyrosineatypical protein kinase Ccell polaritycell signalingmembrane recruitmenttyrosine phosphorylation

Identifiers

PMID37211093
PMCPMC10333572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.